Protection from cutaneous leishmaniasis, a chronic ulcerating skin lesion affecting millions, has been achieved historically using live virulent preparations of the parasite. Killed or recombinant Ags that could be safer as vaccines generally require an adjuvant for induction of a strong Th1 respons...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!